The growing interest in alternative routes of drug and vaccine administration has experts predicting that the market for microneedle drug delivery systems could exceed $30 billion by 2025. The industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems. That is why you cannot afford to miss this two-day intensive conference. Pharma Ed's Microneedle & Transdermal Drug Delivery Summit 2021 brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.
Regulators in North America and Europe are requiring stricter standards for the manufacture and safety testing for combination products in both the Pharma and Med device industries. This two-day summit features expert insight into CP product development, and the complex quality, safety, and regulatory compliance issues facing the CP market. Pharma Ed's Combination Products Summit 2021 provides comprehensive coverage of current and future trends in combination products for drugs, biologics and medical devices.
The Cannabis market is exploding. Yet the state of scientific knowledge on medicinal Cannabis remains immature, and the regulatory environment in North America fragmented and contested. That is why you cannot afford to miss Pharma Ed's Canna Pharma. This two-day scientific conference will explicitly link current knowledge and practice in the pharmaceutical and Cannabis industries, providing a forum for scientific dialogue and collaboration aimed at advancing best practices in this growing market.
This two-day conference will examine the safety, quality, and regulatory issues involved in a wide array of contexts central to the pharmaceutical and biotech industries, including drug packaging and delivery components, single-use systems, medical devices, and parenteral drug products. In addition, we will focus closely on the keys to satisfying recent revisions to several applicable USP chapters, ICH Q3E, and the recently revised standards contained in ISO 10993.
The market for inhalation drug delivery devices is expected to reach over $15 billion by 2025. Overcoming challenges in formulation, device design, patient compliance and emerging applications are the keys to your organization's ability to leverage products in this growing market. Pharma Ed's Inhalation Drug Delivery Summit brings together today's leading researchers from both industry and academia to share the latest knowledge in drug and device development, from pre-clinical R&D through phase trials.